GS010 - Efficacy and safety of finite 48-week treatment with the siRNA JNJ-3989 and the capsid assembly modulator (CAM-N) JNJ-6379 in HBeAg negative virologically suppressed (VS) chronic hepatitis B (CHB) patients: results from REEF-2 study

Autor: Agarwal, Kosh, Buti, Maria, van Bömmel, Florian, Lampertico, Pietro, Janczewska, Ewa, Bourliere, Marc, Vanwolleghem, Thomas, Lenz, Oliver, Verbinnen, Thierry, Kakuda, Thomas, Mayer, Cristina, Jerzorwski, John, Beumont-Mauviel, Maria, Kalmeijer, Ronald, Biermer, Michael, Lonjon-Domanec, Isabelle
Zdroj: In Journal of Hepatology July 2022 77 Supplement 1:S8-S8
Databáze: ScienceDirect
Externí odkaz: